These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1952708)

  • 1. [A new case of relapsing hemolytic and uremic syndrome].
    Barsaoui S; Haffani M; Oueslati A; Toumi NH; Bousnina S
    Ann Pediatr (Paris); 1991 Sep; 38(7):487-90. PubMed ID: 1952708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.
    Zimmerhackl LB; Besbas N; Jungraithmayr T; van de Kar N; Karch H; Karpman D; Landau D; Loirat C; Proesmans W; Prüfer F; Rizzoni G; Taylor MC;
    Semin Thromb Hemost; 2006 Mar; 32(2):113-20. PubMed ID: 16575686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
    Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic uremic syndrome. Evaluation of clinical and prognostic factors].
    Palomeque Rico A; Pastor Durán X; Molinero Egea C; Roca González A
    An Esp Pediatr; 1993 Nov; 39(5):391-4. PubMed ID: 8285450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
    J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.
    Bresin E; Daina E; Noris M; Castelletti F; Stefanov R; Hill P; Goodship TH; Remuzzi G;
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):88-99. PubMed ID: 17699195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical presentation and prognostic factors in primary hemolytic-uremic syndrome in adults].
    Pérez Fontán M; Martul EV; Fernández Rivera C; Alvarez A; Fernández Daza J; Valdés F
    Rev Clin Esp; 1989 Nov; 185(7):341-4. PubMed ID: 2623247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of hemolytic uremic syndrome in children. Importance of extrarenal involvement].
    Guyot C; Daniel MD; Roze JC; Renoult E; Dubigeon P; Buzelin F
    Arch Fr Pediatr; 1986 Apr; 43(4):253-8. PubMed ID: 3767586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal histopathology in the hemolytic-uremic syndrome following shigellosis.
    Koster FT; Boonpucknavig V; Sujaho S; Gilman RH; Rahaman MM
    Clin Nephrol; 1984 Feb; 21(2):126-33. PubMed ID: 6373079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
    Candinas D; Keusch G; Schlumpf R; Burger HR; Gmür J; Largiadèr F
    Schweiz Med Wochenschr; 1994 Oct; 124(41):1789-99. PubMed ID: 7973505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
    Gagnadoux MF; Habib R; Gubler MC; Bacri JL; Broyer M
    Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic uraemic syndrome: a review.
    McLigeyo SO
    East Afr Med J; 1999 Mar; 76(3):148-53. PubMed ID: 10442115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foot manifestations of the thrombotic thrombocytopenic purpura hemolytic-uremic syndrome: a review and case report.
    Bibbo C; Davis WH
    J Foot Ankle Surg; 2005; 44(4):301-6. PubMed ID: 16012439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness.
    Edey MM; Mead PA; Saunders RE; Strain L; Perkins SJ; Goodship TH; Kanagasundaram NS
    Am J Kidney Dis; 2008 Mar; 51(3):487-90. PubMed ID: 18295065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic uremic syndrome: defining the need for long-term follow-up.
    Small G; Watson AR; Evans JH; Gallagher J
    Clin Nephrol; 1999 Dec; 52(6):352-6. PubMed ID: 10604642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hemolytic uremic syndrome during oral contraception.
    Hauglustaine D; Van Damme B; Vanrenterghem Y; Michielsen P
    Clin Nephrol; 1981 Mar; 15(3):148-53. PubMed ID: 6168423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.